Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 38 holding rows worth $1,018,739,385.

Accession
0000919574-24-001474
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 38 entries on the cover page, a total value of $1,018,739,385 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,018,739,385 with VALUE read as dollars as filed, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock5,714,775$163,899,747dollars as filed
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock8,707,165$141,491,431dollars as filed
SAREPTA THERAPEUTICS INC803607100COM1,006,500$97,056,795dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock7,387,943$81,341,252dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY1,091,867$44,504,499dollars as filed
INTELLIA THERAPEUTICS INC45826J105COM1,450,000$44,210,500dollars as filed
ILLUMINA INC452327109COM313,000$43,582,120dollars as filed
VERVE THERAPEUTICS INC92539P101COM3,009,094$41,946,770dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock195,000$37,324,950dollars as filed
SOMALOGIC INC83444K105COM12,604,275$31,888,816dollars as filed
EXACT SCIENCES CORP COM30063P105Stock420,000$31,071,600dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM326,378$30,105,107dollars as filed
PLIANT THERAPEUTICS INC729139105COM1,577,108$28,561,426dollars as filed
DENALI THERAPEUTICS INC COM24823R105Stock1,300,000$27,898,000dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock1,033,811$20,945,011dollars as filed
TENAYA THERAPEUTICS INC87990A106COM6,381,377$20,675,661dollars as filed
BEAM THERAPEUTICS INC07373V105COM528,000$14,372,160dollars as filed
ABCELLERA BIOLOGICS INC COM00288U106Stock2,360,129$13,476,337dollars as filed
TANGO THERAPEUTICS INC87583X109COM1,188,349$11,764,655dollars as filed
CENTURY THERAPEUTICS INC15673T100COM3,206,380$10,645,182dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock1,175,750$10,640,538dollars as filed
NEUROGENE INC64135M105COMMON STOCK524,616$10,167,058dollars as filed
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,035,859$10,161,777dollars as filed
GENEDX HOLDINGS CORP81663L200COM CL A3,095,511$8,512,655dollars as filed
FATE THERAPEUTICS INC31189P102COM2,050,000$7,667,000dollars as filed
CODEXIS INC192005106COM2,000,000$6,100,000dollars as filed
2SEVENTY BIO INC COMMON STOCK901384107Stock1,182,623$5,049,800dollars as filed
ABSCI CORPORATION00091E109COM973,260$4,087,692dollars as filed
ILLUMINA INC452327109COM25,000$3,481,000dollars as filedcall
PRIME MEDICINE INC74168J101COM367,175$3,253,171dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM150,000$3,241,500dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM510,882$2,886,483dollars as filed
STANDARD BIOTOOLS INC34385P108COM1,200,000$2,652,000dollars as filed
EXSCIENTIA PLC30223G102ADS213,900$1,371,099dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY25,000$1,019,000dollars as filedcall
LIANBIO ADR53000N108COM206,415$922,675dollars as filed
SINGULAR GENOMICS SYSTEMS IN82933R100COM1,323,885$609,119dollars as filed
KRONOS BIO INC50107A104COM123,839$154,799dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-24-001474this filing2024-02-14acceptance time not in the bulk data set